Trial Outcomes & Findings for Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity (NCT NCT02152826)

NCT ID: NCT02152826

Last Updated: 2020-09-18

Results Overview

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

80 participants

Primary outcome timeframe

36 days

Results posted on

2020-09-18

Participant Flow

Participant milestones

Participant milestones
Measure
Potassium Oxalate Gel
Professional application Potassium oxalate: Professional application
Potassium Oxalate Liquid
Professional application Potassium oxalate: Professional application
Overall Study
STARTED
45
35
Overall Study
COMPLETED
44
34
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Potassium Oxalate Gel
n=45 Participants
Professional application Potassium oxalate: Professional application
Potassium Oxalate Liquid
n=35 Participants
Professional application Potassium oxalate: Professional application
Total
n=80 Participants
Total of all reporting groups
Age, Continuous
46.7 years
STANDARD_DEVIATION 13.26 • n=5 Participants
45.7 years
STANDARD_DEVIATION 13.72 • n=7 Participants
46.3 years
STANDARD_DEVIATION 13.39 • n=5 Participants
Sex: Female, Male
Female
23 Participants
n=5 Participants
20 Participants
n=7 Participants
43 Participants
n=5 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
15 Participants
n=7 Participants
37 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Asian Indian
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Asian Oriental
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Black
10 Participants
n=5 Participants
11 Participants
n=7 Participants
21 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Caucasian
22 Participants
n=5 Participants
16 Participants
n=7 Participants
38 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Hispanic
5 Participants
n=5 Participants
3 Participants
n=7 Participants
8 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnicity · Multi-Racial
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 36 days

Population: Eighty (80) subjects received study products. Seventy-eight (78) subjects completed the study. Two subjects dropped from the study after the Day 6 visit.

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure.

Outcome measures

Outcome measures
Measure
Potassium Oxalate Gel
n=44 Participants
Professional application Potassium oxalate: Professional application
Potassium Oxalate Liquid
n=34 Participants
Professional application Potassium oxalate: Professional application
Change From Baseline for Air Challenge
-1.18 units on a scale
Standard Error 0.46
-1.10 units on a scale
Standard Error 0.56

SECONDARY outcome

Timeframe: 36 days

Population: Eighty (80) subjects received product. Seventy-eight (78) subjects completed the study. Two subjects dropped from the study after the Day 6 visit.

Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced.

Outcome measures

Outcome measures
Measure
Potassium Oxalate Gel
n=44 Participants
Professional application Potassium oxalate: Professional application
Potassium Oxalate Liquid
n=34 Participants
Professional application Potassium oxalate: Professional application
Change From Baseline in Dentin Sensitivity
Schiff Air Index
-1.18 untis on a scale
Standard Error 0.46
-1.10 untis on a scale
Standard Error 0.56
Change From Baseline in Dentin Sensitivity
Visual Analog Scale
-27.18 untis on a scale
Standard Error 21.10
-30.57 untis on a scale
Standard Error 18.16

Adverse Events

Potassium Oxalate Gel

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Potassium Oxalate Liquid

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Potassium Oxalate Gel
n=45 participants at risk
Professional application Potassium oxalate: Professional application
Potassium Oxalate Liquid
n=35 participants at risk
Professional application Potassium oxalate: Professional application
Gastrointestinal disorders
Stomatitis
2.2%
1/45 • 36 days
0.00%
0/35 • 36 days
Gastrointestinal disorders
Tongue coated
2.2%
1/45 • 36 days
0.00%
0/35 • 36 days
Infections and infestations
Gingival abscess
0.00%
0/45 • 36 days
2.9%
1/35 • 36 days

Additional Information

Clinical Trial Manager

The Procter & Gamble Company

Phone: 513-622-2489

Results disclosure agreements

  • Principal investigator is a sponsor employee Written consent from Sponsor
  • Publication restrictions are in place

Restriction type: OTHER